Sulzer (SUN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Achieved record sales, order intake, and profitability in 2025, with strong growth in aftermarket, water, and services segments, and improved operational performance.
Strategy focused on operational excellence, commercial discipline, and customer-centric investments, strengthening supply chains and delivery.
Large project delays in oil & gas and chemicals shifted significant order volume into 2026, but underlying growth momentum remains robust.
Dividend proposed to increase by CHF 0.50 to CHF 4.75 per share, reflecting confidence in ongoing performance.
Free cash flow was CHF 212.5 million, with a strong cash position of CHF 927.3 million at year-end.
Financial highlights
Order intake grew by 2.1% year-over-year, with a book-to-bill ratio of 1.06 and strong aftermarket and water segments.
Sales increased by 5.6% year-over-year to CHF 3,555.4 million, with EBITDA reaching a record CHF 556.2 million (15.6% margin).
Basic earnings per share rose 18.8% to CHF 8.68; return on capital employed up 140 bps to 21.1%.
Negative FX impact reduced order intake and sales by CHF 190 million and EBITDA by CHF 40 million.
Net debt/EBITDA stable at 1.0; equity ratio improved to 28.3%.
Outlook and guidance
2026 guidance: order intake growth of 1–5%, sales growth of 2–5%, EBITDA margin targeted above 16.5%.
H1 2026 expected to be muted due to timing of large projects; stronger momentum anticipated in H2.
Aftermarket, water, and small-scale projects expected to drive continued growth, with new technology segments growing in key regions.
CapEx expected to remain at similar levels for 2026 and 2027.
Order backlog at year-end was CHF 2,255.6 million, supporting future revenue.
Latest events from Sulzer
- Order and sales growth drove higher profitability and upgraded 2024 guidance.SUN
H1 20242 Feb 2026 - Targets above-market growth, >17% EBITDA margin, and >22% ROCE by 2028, fully self-financed.SUN
CMD 20241 Feb 2026 - Double-digit sales and order growth, higher margins, and strong 2025 outlook driven by backlog.SUN
H2 202416 Dec 2025 - Order intake recovers, Services grow double digits, Chemtech hit by delays; guidance reaffirmed.SUN
Q3 2025 TU2 Nov 2025 - Sales, EBITDA, and net income up; Chemtech lagged, outlook and dividend increased.SUN
H1 202524 Jul 2025 - Stable Q1 order intake and confirmed guidance, with strong Flow and Services growth.SUN
Q1 2025 TU23 Jun 2025 - Order intake up 9.2% year-over-year; full-year guidance and profitability targets reaffirmed.SUN
Q3 2024 TU13 Jun 2025